For over 50 years, CRA has been a premier consulting firm. Each of our practice areas is highly regarded, and our consultants are recognized for their creative and multi-disciplinary approach to solving our clients’ complex problems in the US and throughout the world.
In this discussion of 'commercially reasonable efforts,' Dr. Greg Bell explains how understanding the strategy behind a pharmaceutical product launch can inform development obligations in contract and licensing agreements. Click below to read the article.
